Libro Non-Adhesive Embolization Agent: EVOH, DMSO and Tantalum

Advanced Formula and Precision in Flow Control
•Composition: A unique blend of EVOH (Ethylene Vinyl Alcohol Copolymer), DMSO (Dimethyl Sulfoxide), and Tantalum.
•Non-Adhesive Formula: Ensures controlled and precise embolization, reducing the risk of non-target embolization.
•High Radiopacity: Tantalum provides excellent visibility under imaging, ensuring accurate deployment.

Optimal Outcomes for 3 Different Formulas
•Its non-adhesive nature ensures stable and cohesive embolus formation without compromising the vessel walls.
•Biocompatible: The materials used are safe and well-tolerated by the body.
•Versatile Use: Suitable for a wide range of neurovascular applications.
•Stable and Consistent: Provides reliable performance for every procedure.

Libro: Setting the Standard in Controlled Vascular Occlusion
The agent’s solubility in DMSO enables delivery through microcatheters, ensuring targeted application and reducing the risk of non-target embolization. The inclusion of Tantalum powder enhances radiopacity, allowing for real-time monitoring and precise placement, further ensuring procedural success.

Libro Non-Adhesive Embolization Agent represents a paradigm shift in vascular occlusion, combining Ethylene Vinyl Alcohol Copolymer (EVOH), Dimethyl Sulfoxide (DMSO), and Tantalum powder to deliver a state-of-the-art solution.

This unique blend ensures a stable and cohesive embolus formation upon contact with blood, while maintaining non-adhesive properties to preserve the integrity of the vessel walls. Libro’s EVOH component guarantees durability and biocompatibility, ensuring long-term patient safety.

The solubility in DMSO allows for delivery through microcatheters, enhancing the precision of application and minimizing the risk of non-target embolization. Additionally, the inclusion of Tantalum powder ensures superior radiopacity, providing clinicians with real-time monitoring capabilities and ensuring precise placement during procedures.

Choose Libro for a reliable, non-adhesive, and precisely controllable embolization agent, setting new standards in patient care and procedural success.

EVOH Base (Ethylene Vinyl Alcohol Copolymer)
•Stable Embolic Matrix: Once injected, the EVOH solution solidifies upon contact with blood or aqueous medium, forming an occlusive cast within the targeted vasculature.
•Non-Adhesive: Minimizes risk of catheter entrapment, enabling smoother microcatheter withdrawal post-embolization.

DMSO Solvent
•Uniform Dispersion: Maintains the EVOH in a liquid state until injection, allowing for precise and controlled delivery.
•Gradual Precipitation: The polymer solidifies from the outer surface inward, helping operators monitor and fine-tune deposition patterns.

Radiopacity
•Integrated Tantalum Powder (or similar radiopaque agent) ensures fluoroscopic visibility, enabling real-time feedback on embolic material positioning.